Yutaro Mori

3.5k total citations · 1 hit paper
95 papers, 2.4k citations indexed

About

Yutaro Mori is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Yutaro Mori has authored 95 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Nephrology. Recurrent topics in Yutaro Mori's work include Microbial Metabolic Engineering and Bioproduction (11 papers), Renal and related cancers (11 papers) and Enzyme Catalysis and Immobilization (9 papers). Yutaro Mori is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (11 papers), Renal and related cancers (11 papers) and Enzyme Catalysis and Immobilization (9 papers). Yutaro Mori collaborates with scholars based in Japan, United States and United Kingdom. Yutaro Mori's co-authors include Takayuki Enomoto, Kosuke Yoshihara, Shuhei Noda, Kaoru Yamawaki, Tatsuya Ishiguro, Shinichi Uchida, Eisei Sohara, Takayasu Mori, Tatemitsu Rai and Ryo Tamura and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yutaro Mori

82 papers receiving 2.4k citations

Hit Papers

Clonal Expansion and Diversification of Cancer-Associated... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaro Mori Japan 27 1.1k 391 351 267 258 95 2.4k
Amir Mehdizadeh Iran 29 968 0.9× 78 0.2× 299 0.9× 217 0.8× 501 1.9× 132 2.4k
Aria Masoudifar Iran 17 1.4k 1.3× 63 0.2× 77 0.2× 48 0.2× 427 1.7× 20 2.3k
Hongbo Wang China 22 765 0.7× 21 0.1× 149 0.4× 230 0.9× 197 0.8× 99 1.8k
Junjun Wang China 27 1.5k 1.3× 58 0.1× 129 0.4× 47 0.2× 247 1.0× 83 2.4k
Charles A. Frolik United States 32 2.6k 2.3× 167 0.4× 46 0.1× 44 0.2× 164 0.6× 57 3.8k
Yun‐Jung Choi South Korea 22 482 0.4× 60 0.2× 136 0.4× 21 0.1× 117 0.5× 45 1.9k
Jia Huang China 20 457 0.4× 43 0.1× 381 1.1× 31 0.1× 209 0.8× 52 1.4k
Shinya Akatsuka Japan 25 1.1k 1.0× 16 0.0× 154 0.4× 93 0.3× 228 0.9× 65 2.5k
Bin Zhao China 32 1.6k 1.4× 43 0.1× 44 0.1× 62 0.2× 213 0.8× 100 3.4k

Countries citing papers authored by Yutaro Mori

Since Specialization
Citations

This map shows the geographic impact of Yutaro Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaro Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaro Mori more than expected).

Fields of papers citing papers by Yutaro Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaro Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaro Mori. The network helps show where Yutaro Mori may publish in the future.

Co-authorship network of co-authors of Yutaro Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaro Mori. A scholar is included among the top collaborators of Yutaro Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaro Mori. Yutaro Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nonaka, Daisuke, et al.. (2025). Biosynthesis of 2,5-pyridinedicarboxylate from glucose via p-aminobenzoic acid in Escherichia coli. Metabolic Engineering. 92. 252–261.
2.
Mandai, Shintaro, Yuta Nakano, Yutaro Mori, et al.. (2025). Perioperative antihypertensive medications and effects on functional decline and mortality in non-cardiac surgery. European Heart Journal Open. 5(4). oeaf096–oeaf096.
3.
Hirata, Yuuki, Daisuke Nonaka, Akihiko Kondo, et al.. (2025). Metabolic engineering of Escherichia coli for 4-nitrophenylalanine production via the 4-aminophenylalanine synthetic pathway. Metabolic Engineering. 91. 171–180. 1 indexed citations
4.
Fujimaru, Takuya, Takayasu Mori, Motoko Chiga, et al.. (2024). Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology. Kidney International Reports. 9(4). 994–1004. 5 indexed citations
5.
Ueda, Haruka, Tatsuya Ishiguro, Yutaro Mori, et al.. (2024). Glycolysis-mTORC1 crosstalk drives proliferation of patient-derived endometrial cancer spheroid cells with ALDH activity. Cell Death Discovery. 10(1). 435–435.
6.
Nakano, Yuta, Shintaro Mandai, Daiei Takahashi, et al.. (2024). Sex disparities in the risk of urgent dialysis following acute aortic dissections in Japan. iScience. 27(8). 110577–110577.
7.
Fujimaru, Takuya, Takayasu Mori, Akinari Sekine, et al.. (2024). Importance of IFT140 in Patients with Polycystic Kidney Disease Without a Family History. Kidney International Reports. 9(9). 2685–2694.
8.
9.
Hirata, Yuuki, Mariko Nakano, Daisuke Nonaka, et al.. (2023). Hydroxybenzoic Acid Production Using Metabolically Engineered Corynebacterium glutamicum. 1(2). 10010–10010.
10.
Nakano, Yuta, Shintaro Mandai, Shotaro Naito, et al.. (2023). Effect of osteosarcopenia on longitudinal mortality risk and chronic kidney disease progression in older adults. Bone. 179. 116975–116975. 18 indexed citations
11.
Mandai, Shintaro, Yutaro Mori, Fumiaki Ando, et al.. (2023). National Trends in Mortality and Urgent Dialysis after Acute Hypertension in Japan From 2010 Through 2019. Hypertension. 80(12). 2591–2600. 2 indexed citations
12.
Mori, Takayasu, Shintaro Mandai, Yutaro Mori, et al.. (2023). Thrombocytopenia during avacopan administration: A case report. International Journal of Rheumatic Diseases. 26(8). 1603–1607. 3 indexed citations
13.
Yamaguchi, Manako, Hirofumi Nakaoka, Kazuaki Suda, et al.. (2022). Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epithelium. Nature Communications. 13(1). 943–943. 34 indexed citations
14.
Mori, Yutaro, et al.. (2021). Human Primary Renal Tubuloids as Tools for Pathophysiology and Nephrotoxicity Assessment. Journal of the American Society of Nephrology. 32(10S). 198–198. 1 indexed citations
15.
Wiraja, Christian, et al.. (2021). Nephrotoxicity Assessment with Human Kidney Tubuloids Using Spherical Nucleic Acid-Based mRNA Nanoflares. Journal of the American Society of Nephrology. 32(10S). 198–199. 1 indexed citations
16.
Li, Li, Pierre Galichon, Xiaoyan Xiao, et al.. (2021). Orphan nuclear receptor COUP‐TFII enhances myofibroblast glycolysis leading to kidney fibrosis. EMBO Reports. 22(6). e51169–e51169. 27 indexed citations
17.
Ichimura, Takaharu, Mahmoud L. Nasr, Samuel Mon-Wei Yu, Yutaro Mori, & Joseph V. Bonventre. (2020). Kidney Injury Molecule 1 Is a Receptor for SARS-CoV-2. Journal of the American Society of Nephrology. 31(10S). 296–296. 1 indexed citations
18.
Kishi, Seiji, Craig R. Brooks, Kensei Taguchi, et al.. (2019). Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses. Journal of Clinical Investigation. 129(11). 4797–4816. 88 indexed citations
19.
20.
Tamura, Ryo, Hirofumi Nakaoka, Kosuke Yoshihara, et al.. (2018). Novel MXD4–NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma. Genes Chromosomes and Cancer. 57(11). 557–563. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026